Tag: project

PHILADELPHIA and VANCOUVER, British Columbia, Aug. 05, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care announced today that the Company’s board of directors has approved the consolidation (the “Consolidation”) of the Company’s issued and outstanding common shares (the “Common Shares”) on the basis of one (1) post-Consolidation Common Share for every ten (10) pre-Consolidation Common Shares. The Consolidation is being implemented to ensure that the Company continues to comply with the listing requirements of The Nasdaq Capital Market (the “Nasdaq”).

CALGARY, Alberta, Aug. 05, 2025 (GLOBE NEWSWIRE) --

Second Quarter Highlights

VANCOUVER, British Columbia, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Diversified Royalty Corp. (TSX: DIV and DIV.DB.A) (the “Corporation” or “DIV”) is pleased to announce that its board of directors has approved a cash dividend of $0.02292 per common share for the period of August 1, 2025 to August 31, 2025, which is equal to $0.275 per common share on an annualized basis. The dividend will be paid on August 29, 2025 to shareholders of record as of the close of business on August 15, 2025.

VERO BEACH, Florida, Aug. 05, 2025 (GLOBE NEWSWIRE) -- ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) (“ARMOUR” or the “Company”) today announced that it is commencing an underwritten public offering of 18,500,000 shares of common stock. ARMOUR expects to grant the underwriters a 30-day option to purchase up to 2,775,000 additional shares of its common stock.